| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.096 | 0.09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |